scholarly article | Q13442814 |
P2093 | author name string | Breslow JL | |
Zannis VI | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1759-1762 | |
P577 | publication date | 1980-03-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia | |
P478 | volume | 255 |
Q69375330 | Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apo E and apo CII |
Q71713135 | Apolipoprotein E and cholesterol metabolism |
Q35763533 | Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors |
Q37601028 | Apolipoprotein E synthesis in human kidney, adrenal gland, and liver |
Q40326331 | Apolipoprotein E. |
Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
Q37598700 | Baculovirus-mediated expression of human apolipoprotein E in Manduca sexta larvae generates particles that bind to the low density lipoprotein receptor |
Q30557542 | Epigenetic signature and enhancer activity of the human APOE gene. |
Q33669967 | Genetics of the apolipoprotein-E isoprotein system in man. |
Q35201063 | Human apolipoprotein E isoprotein subclasses are genetically determined |
Q37370803 | Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells |
Q35205937 | Identical Structural and Receptor Binding Defects in Apolipoprotein E2 in Hypo-, Normo-, and Hypercholesterolemic Dysbetalipoproteinemia |
Q36991404 | Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype |
Q34606014 | Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects |
Q35580326 | Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia |
Q36656419 | Pharmacogenetics of target genes across the warfarin pharmacological pathway |
Q36306690 | Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects |
Q40135663 | The metabolic basis of familial hypercholesterolaemia |
Q70431348 | [Apolipoproteinopathies] |
Q51650561 | [The apolipoproteins in man ] |
Search more.